VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 300 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2017. The put-call ratio across all filers is 2.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $200,000 | +1.0% | 9,634 | -15.7% | 0.03% | 0.0% |
| Q2 2017 | $198,000 | +57.1% | 11,434 | 0.0% | 0.03% | +62.5% |
| Q1 2017 | $126,000 | -71.9% | 11,434 | -62.9% | 0.02% | -71.9% |
| Q4 2016 | $448,000 | +59.4% | 30,834 | +169.1% | 0.06% | +50.0% |
| Q3 2016 | $281,000 | -51.8% | 11,460 | -60.4% | 0.04% | -48.6% |
| Q2 2016 | $583,000 | +191.5% | 28,970 | +281.2% | 0.07% | +196.0% |
| Q1 2016 | $200,000 | -70.4% | 7,600 | +14.3% | 0.02% | -67.5% |
| Q4 2015 | $676,000 | – | 6,652 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,586,582 | $864,160,000 | 32.02% |
| FARLEY CAPITAL L.P. | 341,518 | $44,807,000 | 30.12% |
| LeVasseur Capital Partners LLC | 190,404 | $24,981,000 | 29.94% |
| Ruane, Cunniff & Goldfarb | 34,494,015 | $4,525,615,000 | 23.97% |
| ValueAct Holdings | 18,923,877 | $2,482,813,000 | 16.64% |
| White River Investment Partners, LLC | 90,099 | $11,820,000 | 16.35% |
| Tesuji Partners | 1,368,040 | $179,487,000 | 15.45% |
| Arrow Capital Management, LLC | 197,500 | $25,912,000 | 15.11% |
| Hound Partners | 3,576,998 | $469,302,000 | 14.87% |
| Brahman Capital Corp. | 4,457,153 | $584,778,000 | 12.82% |